Unexplained Infertility Clinical Trial
Official title:
A Randomized, Double Blind, Controlled, Parallel Groups, Multi-center Phase II Clinical Study of Lidocaine Pertubation as a Treatment for Couples With Unexplained Infertility
The present investigation is evaluating a method for improving pregnancy outcome of couples with unexplained infertility. The method utilizes an adjuvant pre-treatment prior to insemination, that is pertubation, i.e. flushing the uterus and fallopian tubes before insemination with a specially developed solution with the aim to increase fertility. The clinical trial is a phase II double blind, randomized, controlled and multi-center trial .
Status | Recruiting |
Enrollment | 120 |
Est. completion date | March 31, 2019 |
Est. primary completion date | May 31, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years to 38 Years |
Eligibility |
Inclusion Criteria: Females with, unexplained infertility, 20-38 years of age. Normal menstrual cycle length of 26-35 days, male partner 20-70 years of age, Duration of infertility should have lasted more than one year and subject should have signed informed consent. Couples must fulfil all laboratory tests for inclusion, negative HIV-1, HCV, HBV, CMV virology, chlamydia and syphilis. For female also negative toxoplasmosis, rubella and hormonal screen within normal range. Furthermore patent fallopian tubes should be confirmed by ultrasound hysterosalpingography and males should present a normal semen analysis Exclusion Criteria: Continuous treatment with NSAID, corticosteroids or other drugs, which can cause an increased risk of infection, clinical signs of PID, known hypersensitivity to local anaesthetics, non-patent fallopian tubes, abnormal uterine cavity, submucous myoma > 2 cm in diameter, any disease or laboratory finding considered of importance by the investigator not to include the patient, laparoscopically confirmed endometriosis of greater severity than mild, endometriosis of any severity with adhesions. More than 2 previous inseminations or previous unsuccessful IVF treatment. |
Country | Name | City | State |
---|---|---|---|
Poland | InviMed-T sp. z o.o | Warszawa |
Lead Sponsor | Collaborator |
---|---|
Isifer AB | Ferring Pharmaceuticals, Vinnova |
Poland,
Edelstam G, Sjösten A, Bjuresten K, Ek I, Wånggren K, Spira J. A new rapid and effective method for treatment of unexplained infertility. Hum Reprod. 2008 Apr;23(4):852-6. doi: 10.1093/humrep/den003. Epub 2008 Feb 15. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pregnancy rate | serum-HCG | day 14-17 after IUI | |
Secondary | Baby take home rate | Delivery of baby | At delivery / Miscarriage |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04169451 -
IUI With Letrozole Versus in Natural Cycle
|
N/A | |
Completed |
NCT01672801 -
Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT
|
N/A | |
Completed |
NCT01232465 -
Impact of Sperm DNA Integrity on In Vitro Cycles
|
N/A | |
Not yet recruiting |
NCT01237535 -
Luteal Phase Support With Progesterone Versus Estrogen and Progesterone on Pregnancy Rates
|
Phase 4 | |
Completed |
NCT02272439 -
Endocrine Disrupting Chemicals: Potential Effects on Male and Female Reproductive Health in Saskatchewan
|
N/A | |
Terminated |
NCT00650754 -
Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility
|
Phase 2/Phase 3 | |
Recruiting |
NCT04754243 -
New Protocol in Unexplained Infertility
|
Phase 4 | |
Completed |
NCT03018314 -
Serum Kisspeptin Levels in Infertile Women
|
N/A | |
Completed |
NCT02488434 -
The Effects of Using Fertile Chip in Sperm Selection for Intracytoplasmic Sperm Injection in Unexplained Infertility
|
Phase 3 | |
Completed |
NCT02739516 -
Dual FSH/HCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility
|
Phase 3 | |
Completed |
NCT02628756 -
Endometrial Injury in Women With Unexplained Infertility
|
N/A | |
Completed |
NCT01044862 -
Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation
|
Phase 3 | |
Completed |
NCT04465045 -
Unexplained Infertility Treated by Hysteroscopy-laparoscopy
|
||
Completed |
NCT03461601 -
Uterine Flushing With Human Chorionic Gonadotrophin and Unexplained Infertility
|
N/A | |
Completed |
NCT01859520 -
Swim up and Gradient Methods Used in Assisted Reproduction Techniques on DNA Fragmentation of Spermatozoa
|
N/A | |
Active, not recruiting |
NCT03828786 -
Uterine Scratching in Intra-Uterine Insemination
|
N/A | |
Completed |
NCT03397693 -
Assessment of Endometrial Thickness & Subendometrial Perfusion by 3D Power Doppler in Women With Unexplained Infertility and PCOS.
|
||
Withdrawn |
NCT04955574 -
Probiotic and Antibiotic Therapies in Women With Unexplained Infertility
|
Phase 2 | |
Not yet recruiting |
NCT03398993 -
Effect of Endometrial Injury in Couples With Unexplained Infertility
|
N/A | |
Completed |
NCT02861105 -
The Effect of LMWH on ICSI in Patients With Unexplained Infertility and Negative Immunological Markers
|
Phase 4 |